JPRN-UMIN000014954Completed未知
Cohort study evaluating the efficacy of denosumab to protect against aromatase inhibitor-induced bone loss in Japanese breast cancer patients. - Cohort study evaluating the efficacy of denosumab to protect against aromatase inhibitor-induced bone loss in Japanese breast cancer patients. (CYBORG003)
CYBORG (Chiba Youth Breast Oncology Research Group)0 sites500 target enrollmentStarted: August 26, 2014Last updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 500
Study Overview
Brief Summary
The number of registered patient is too small than expected, so we are unable to make a planned analysis.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- Female
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. Subject with prior allergy history to therapeutic agents used in this study 2. Evidence of with hypocalcemia 3. Known renal deficiency 4. Any organic or psychiatric disorder that, in the opinion of the investigator, might prevent the subject from completing the study or interfere with the interpretation of the study results.
Investigators
Similar Trials
Completed
Phase 4
Efficacy of coronary artery calcification on DenosumabPatients with osteoporosis with coronary artery calcificationosteoporosis, coronary artery calcificationJPRN-jRCT1031190025Kubota Naoki1
Completed
Phase 2
Efficacy and safety of weekly nab-paclitaxel plus CBDCA in patients with CUPcancer of unknown primaryCUP, nab-Paclitaxel,CBDCAJPRN-jRCTs051180084Yagi Toshinari17
Active, not recruiting
Phase 1
A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis. FREEDOM (Fracture REduction Evaluation of Denosumab in Osteoporosis every 6 Months)Treatment of postmenopausal osteoporosisMedDRA version: 8.1 Level: LLT Classification code 10031285 Term: Osteoporosis postmenopausalEUCTR2004-000138-35-GBAmgen Inc7,869
Completed
Not Applicable
Multi-center study for evaluating distribution of RHI in Japanese subjects without cardiovascular diseases for estimating clinical reference value of RHI in JapaJPRN-UMIN000021454Jinnouchi Hospital20
Completed
Phase 2
Trial of the effectiveness of nutritional intervention for patients who are administered TS-1 after surgical resection of pancreatic cancerpancreatic cancerJPRN-jRCT1051180068Toyama Hirochika35